PACIRA BIOSCIENCES, INC. Payments for Postemployment Benefits
PACIRA BIOSCIENCES, INC. (PCRX) reported Payments for Postemployment Benefits of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForPostemploymentBenefits · last filed 2020-05-07
- PACIRA BIOSCIENCES, INC. payments for postemployment benefits for the quarter ending 2020-03-31 was $0.00.
- PACIRA BIOSCIENCES, INC. payments for postemployment benefits for the quarter ending 2019-12-31 was $27.00K.
- PACIRA BIOSCIENCES, INC. payments for postemployment benefits for the quarter ending 2019-09-30 was $177.00K.
- PACIRA BIOSCIENCES, INC. payments for postemployment benefits for the quarter ending 2017-12-31 was $481.00K.
- PACIRA BIOSCIENCES, INC. payments for postemployment benefits for fiscal 2019 was $348.00K.
- PACIRA BIOSCIENCES, INC. payments for postemployment benefits for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- PACIRA BIOSCIENCES, INC. payments for postemployment benefits for fiscal 2017 was $303.00K.
| Period end | Payments for Postemployment Benefits 3 month | Payments for Postemployment Benefits 6 month | Payments for Postemployment Benefits 9 month | Payments for Postemployment Benefits 12 month |
|---|---|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | $27.00K derived: sum of 2 quarters · filed 2020-05-07 | $204.00K derived: sum of 3 quarters · filed 2020-05-07 | |
| 2019-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $204.00K derived: sum of 2 quarters · filed 2020-02-21 | $348.00K 10-K · filed 2020-02-21 | |
| 2019-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $321.00K 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $144.00K 10-Q · filed 2019-08-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-21 | |||
| 2017-12-31 | $481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $303.00K 10-K · filed 2020-02-21 | ||
| 2017-09-30 | -$178.00K 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |